CSI Market
Sign In | Register

Eloxx Pharmaceuticals Inc (ELOX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ELOX Annual Balance Sheets →
A period-by-period view of the balance sheet from Eloxx Pharmaceuticals Inc to Sep 30 2023 helps clarify how Mar 31 2026's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ELOX/balance-sheets
https://api.csimarket.com/api/v1/companies/ELOX/fundamentals
https://api.csimarket.com/api/v1/companies/ELOX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
(Dec 31 2025) (Dec 31 2024) (Dec 31 2023) (Sep 30 2023)
Assets
Cash & cash equivalent6.36
Cash & Short-term Investments6.00
Other Receivables0.00
Other Current Assets0.01
Prepaid Expense And Other Assets Current2.13
Total Current Assets8.50
Equipment/Property/Plant Net0.00
Long-term investments0.00
Restricted Cash Current0.01
Operating Lease Right Of Use Asset-
Total Assets8.50
Liabilities
Accounts Payable, Current AC3.03
Accrued Liabilities, Current AC1.24
Derivative Liability, Current DE0.00
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Total Current Liabilities16.09
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Advances From Collaboration Partners Current11.82
Total Liabilities16.09
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock296.70
Retained Earnings / Accumulated Deficit-304.33
Other Equity0.00
Common Stockholder's Equity-7.58
Total Stockholder's Equity-7.58
Liabilities & Stockholder's Equity8.50
4 historic quarters locked

Sign in to unlock the full Eloxx Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Eloxx Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-344964

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI